Health Promotion to Reduce Hypertension Patients’ Vulnerability to Coronavirus Disease-19 (COVID-19)

AUTOR(ES)

Nsanzabera, Charles

FONTE

Int. J. Cardiovasc. Sci.

DATA DE PUBLICAÇÃO

2021-02

RESUMO

Abstract Hypertension remains a prominent risk factor for cardiovascular diseases. It is not a coincidence that 23% to 30% of coronavirus disease-19 (COVID-19) confirmed cases are hypertensive patients, and the case-fatality rate of adult COVID-19 cases with hypertension was estimated at 6%. It is important that hypertensive patients be aware of their vulnerability to COVID-19, which may be achieved by a health promotion program in addition to preventive measures.

Documentos Relacionados

• Otorhinolaryngologists and Coronavirus Disease 2019 (COVID-19)
• Coronavirus disease 2019 (COVID-19) in Brasil: information to physical therapists
• Informações sobre o novo coronavírus (COVID-19)
• Coronavirus Disease (COVID-19) Pandemic: An Opportunity Window to Implement Home-Based Cardiac Rehabilitation
• A pragmatic approach and treatment of coronavirus disease 2019 (COVID-19) in intensive care unit